#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metastases to central nervous system Plasma cell myeloma recurrent Drug eruption Sarcoidosis Pneumonia Pouchitis Diffuse large B-cell lymphoma Autoinflammation with infantile enterocolitis Nephrotic syndrome Ewing's sarcoma Hodgkin's disease recurrent Undifferentiated sarcoma Cutaneous calcification Marginal zone lymphoma refractory Glomerulonephritis rapidly progressive More trials…

    Learn about Rare Diseases

    Fabry’s disease – Trials in Disease Myelodysplastic syndrome with excess blasts – Life with Disease Rhabdomyosarcoma recurrent – Trials in Disease Alagille syndrome – Treatment Biotinidase deficiency – Basic Information SAPHO syndrome – Diagnostics Cystic fibrosis lung – Diagnostics Hairy cell leukaemia recurrent – Diagnostics Congenital hypotransferrinaemia – Diagnostics Retinitis pigmentosa More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Propylene Glycol M1P Dipotassium Salt Hydrocortisone Rimegepant ATOVAQUONE Glatiramer Acetate Cytisine Rugonersen MARALIXIBAT Folic Acid Sotalol Hydrochloride Brentuximab Vedotin Piflufolastat (18F) Exl01 GEN1078 Iobitridol Elinzanetant Teplizumab ATIGOTATUG Ganirelix More therapies…

    Learn about Your Condition

    Oedema Lupus nephritis Pulmonary tuberculosis Mast cell activation syndrome Labour pain Lung adenocarcinoma Cholangiocarcinoma Testicular germ cell tumour Nicotine dependence Graft infection Alpha-1 antitrypsin deficiency Mantle cell lymphoma Melanoma recurrent Mucopolysaccharidosis Thyroidectomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eosinophilic oesophagitis

  • Study on Budesonide Tablets for Treating Eosinophilic Esophagitis in Adults

    Recruiting

    3 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Budesonide
    Austria Germany Portugal Spain

  • Study on the Effects of EP-104IAR and Tetracosactide for Adults with Eosinophilic Esophagitis

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Tetracosactide
    • Fluticasone Propionate
    The Netherlands

  • Study on BP1.7881 for Adults with Eosinophilic Esophagitis

    Recruiting

    2 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Bp1.7881A
    France Italy

  • Study on the Use of Viscous Budesonide for Children with Eosinophilic Esophagitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Budesonide
    Italy

  • Study on Etrasimod Arginine for Patients with Ulcerative Colitis, Alopecia Areata, Atopic Dermatitis, and Eosinophilic Esophagitis

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    • Alopecia areata
    • Dermatitis atopic
    Investigated Drugs:
    • Etrasimod Arginine
    Belgium

  • Title: Study of Solrikitug compared to placebo for adults with Eosinophilic Esophagitis to evaluate its effectiveness and safety

    Not recruiting

    2 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Solrikitug
    Belgium Italy The Netherlands Poland Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!